Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06405100
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-05-04
Brief Title:
Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD
Sponsor:
Air Force Military Medical University China
Organization:
Air Force Military Medical University China
Organization Data
Organization:
Air Force Military Medical University China
Class:
OTHER
Study ID:
TAC and ripertamab in MCD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Air Force Military Medical University China
Lead Sponsor Class:
OTHER
Responsible Party:
Shiren sun
Responsible Party Title:
Chief
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Air Force Military Medical University China
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| First Affiliated Hospital Xian Jiaotong University | OTHER |
| Second Affiliated Hospital of Xian Jiaotong University | OTHER |
| The Second Affiliated Hospital of Air Force Military Medical University | UNKNOWN |
| Shaanxi Provincial Peoples Hospital | OTHER |
| Shaanxi Provincial Hospital of Chinese Medicine | UNKNOWN |